Cargando…

PLGA Nanoparticles Containing VCAM-1 Inhibitor Succinobucol and Chemotherapeutic Doxorubicin as Therapy against Primary Tumors and Their Lung Metastases

The treatment of malignant tumors is usually accompanied by poor prognosis due to metastasis of tumor cells. Hence, it is crucial to enhance anti-metastasis efficacy when anti-tumor treatments are conducted. It has been reported that the vascular cell adhesion molecule-1 (VCAM-1) is highly expressed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jie, Wang, Fengling, Xie, Dandan, Zhou, Min, Liao, Jiaxing, Wu, Hongliang, Dai, Yue, Huang, Jingbin, Zhao, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958791/ https://www.ncbi.nlm.nih.gov/pubmed/36839671 http://dx.doi.org/10.3390/pharmaceutics15020349

Ejemplares similares

The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma
por: Muhamad, Nadda, et al.
Publicado: (2020)

Succinobucol’s New Coat — Conjugation with Steroids to Alter Its Drug Effect and Bioavailability
por: Jurček, Ondřej, et al.
Publicado: (2011)

Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
por: Babos, György, et al.
Publicado: (2018)

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
por: Choi, Yongwhan, et al.
Publicado: (2020)

Succinobucol-Eluting Stents Increase Neointimal Thickening and Peri-Strut Inflammation in a Porcine Coronary Model
por: Watt, Jonathan, et al.
Publicado: (2013)

A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer
por: Dan, Zhaoling, et al.
Publicado: (2016)

(131)I-Traced PLGA-Lipid Nanoparticles as Drug Delivery Carriers for the Targeted Chemotherapeutic Treatment of Melanoma
por: Wang, Haiyan, et al.
Publicado: (2017)

Overcoming MDR by Associating Doxorubicin and pH-Sensitive PLGA Nanoparticles Containing a Novel Organoselenium Compound—An In Vitro Study
por: Macedo, Letícia Bueno, et al.
Publicado: (2021)

Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles
por: Zheng, Kangyu, et al.
Publicado: (2021)

Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers
por: Wohlfart, Stefanie, et al.
Publicado: (2011)

VCAM-1 targeted alpha-particle therapy for early brain metastases
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2020)

Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin
por: Hou, Kai, et al.
Publicado: (2021)

Doxorubicin Loaded PLGA Nanoparticle with Cationic/Anionic Polyelectrolyte Decoration: Characterization, and Its Therapeutic Potency
por: Tsai, Li-Hui, et al.
Publicado: (2021)

Local penetration of doxorubicin via intrahepatic implantation of PLGA based doxorubicin-loaded implants
por: Gao, Li, et al.
Publicado: (2019)

Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles
por: Varshosaz, Jaleh, et al.
Publicado: (2017)

Formulation of PLGA nanoparticles containing short cationic peptide nucleic acids
por: Malik, Shipra, et al.
Publicado: (2020)

Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation
por: Jensen, Ditte Marie Krohn, et al.
Publicado: (2010)

Immunostimulatory effects on B cells by the chemotherapeutic drug Doxorubicin
por: Kinn, Johan M, et al.
Publicado: (2011)

Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
por: Kim, Jeongrae, et al.
Publicado: (2022)

Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres
por: Lee, Jimin, et al.
Publicado: (2022)

Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid
por: Wang, Qin, et al.
Publicado: (2019)

PLGA Biodegradable Nanoparticles Containing Perphenazine or Chlorpromazine Hydrochloride: Effect of Formulation and Release
por: Halayqa, Mohammed, et al.
Publicado: (2014)

Development and Characterization of PLGA Nanoparticles Containing 17-DMAG, an Hsp90 Inhibitor
por: Cruz, Kercia P., et al.
Publicado: (2021)

Physical and Functional Characterization of PLGA Nanoparticles Containing the Antimicrobial Peptide SAAP-148
por: Ali, Muhanad, et al.
Publicado: (2023)

Supermagnetic Human Serum Albumin (HSA) Nanoparticles and PLGA-Based Doxorubicin Nanoformulation: A Duet for Selective Nanotherapy
por: Malinovskaya, Julia, et al.
Publicado: (2022)

Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases
por: Falzone, Nadia, et al.
Publicado: (2018)

A celastrol-based nanodrug with reduced hepatotoxicity for primary and metastatic cancer treatment
por: Zhou, Min, et al.
Publicado: (2023)

Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
por: Gorini, Stefania, et al.
Publicado: (2018)

Doxorubicin and CD-CUR inclusion complex co-loaded in thermosensitive hydrogel PLGA-PEG-PLGA localized administration for osteosarcoma
por: Yang, Zhiming, et al.
Publicado: (2020)

Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity
por: Voci, Silvia, et al.
Publicado: (2023)

Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy
por: He, Peng, et al.
Publicado: (2022)

Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer
por: Zhang, Lingyu, et al.
Publicado: (2020)

Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage
por: Siddharth, Sumit, et al.
Publicado: (2017)

Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A
por: Tang, Li, et al.
Publicado: (2012)

Co-encapsulation of magnetic Fe(3)O(4) nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery
por: Jia, Yanhui, et al.
Publicado: (2012)

Corrigendum to “Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib”
por: Gorini, Stefania, et al.
Publicado: (2019)

In Vitro and In Vivo Effect of pH-Sensitive PLGA-TPGS-Based Hybrid Nanoparticles Loaded with Doxorubicin for Breast Cancer Therapy
por: Fernandes, Renata S., et al.
Publicado: (2022)

Development of composite PLGA microspheres containing exenatide-encapsulated lecithin nanoparticles for sustained drug release
por: Dong, Ni, et al.
Publicado: (2020)

PLGA-Based Nanoparticles in Cancer Treatment
por: Rezvantalab, Sima, et al.
Publicado: (2018)

PEG–PLGA nanoparticles for encapsulating ciprofloxacin
por: Watcharadulyarat, Natsorn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s971h2d2a3686tejcif4ar830l